Search
Now showing items 1-3 of 3
Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy
(Baishideng Publishing Group Co, 2021)
BACKGROUND Hypoxic-ischemic encephalopathy (HIE) is a leading cause of morbidity and mortality in the adult as well as in the neonate, with limited options for treatment and significant dysfunctionality. AIM To investigate ...
Functional recovery after wharton’s jelly–derived mesenchymal stem cell administration in a patient with traumatic spinal cord injury: a pilot study
(Gelenos, 2021)
The use of stem cells in the treatment of traumatic spinal cord injury (SCI) in recent years has provided promising results. Different sources
of cells for transplantation have been used, including mesenchymal stem cells ...
Functional recovery after wharton's jelly-derived mesenchymal stem cell administration in a patient with traumatic brain injury: a pilot study
(TURKISH NEUROSURGICAL SOC, 2020)
AIM: To introduce a traumatic brain injury (TBI) patient who underwent stem cell transplantation (SCT) in order to minimize the remaining injury deficiencies.
MATERIAL and METHODS: This study included a 29 years old ...
